New Shot-Based immunotherapy combo tested for advanced lung cancer
NCT ID NCT06946797
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 30 times
Summary
This study tests two different dosing schedules of a subcutaneous (under-the-skin) form of the immunotherapy drug nivolumab, given together with intravenous ipilimumab and chemotherapy, in people with advanced or recurrent non-small cell lung cancer who have not had prior treatment. The main goal is to measure drug levels in the blood and to check safety. About 76 participants will be enrolled.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Local Institution - 0003
Suresnes, Hauts-de-Seine, 92151, France
-
Local Institution - 0009
Sandton, GP, 2196, South Africa
-
Local Institution - 0010
Paris, Île-de-France Region, 75014, France
-
Local Institution - 0011
Thessaloniki, Kentrikí Makedonía, 540 07, Greece
-
Local Institution - 0012
Athens, Attikí, 115 27, Greece
-
Local Institution - 0013
Chaïdári, Attikí, 12462, Greece
-
Local Institution - 0014
Larissa, Thessalía, 41110, Greece
-
Local Institution - 0015
Meldola, Emilia-Romagna, 47014, Italy
-
Local Institution - 0017
Novara, 28100, Italy
-
Local Institution - 0019
Florence, Tuscany, 50134, Italy
-
Local Institution - 0020
Bergamo, Lombardy, 24127, Italy
-
Local Institution - 0031
Soweto, Gauteng, 2013, South Africa
-
Local Institution - 0032
Anchorage, Alaska, 99508, United States
-
Local Institution - 0033
Cleveland, Ohio, 44109, United States
-
Local Institution - 0034
São Paulo, 01246-000, Brazil
-
Local Institution - 0037
Barretos, São Paulo, 14784400, Brazil
-
Local Institution - 0038
Porto Alegre, Rio Grande do Sul, 90035-903, Brazil
-
Local Institution - 0041
Brasília, Federal District, 70200-730, Brazil
-
Local Institution - 0043
Belo Horizonte, Minas Gerais, 30380-490, Brazil
-
Local Institution - 0047
Cleveland, Ohio, 44106, United States
-
Local Institution - 0051
Allentown, Pennsylvania, 18103, United States
-
Local Institution - 0052
Boise, Idaho, 83706, United States
-
Local Institution - 0057
Udine, Friuli Venezia Giulia, 33100, Italy
-
Local Institution - 0062
Los Angeles, California, 90033, United States
-
Local Institution - 0063
Boise, Idaho, 83702, United States
-
Local Institution - 0064
Post Falls, Idaho, 83854, United States
-
Local Institution - 0065
Dijon, Côte-d'Or, 21079, France
-
Local Institution - 0067
Santiago, Santiago Metropolitan, 8420383, Chile
-
Local Institution - 0073
Bucharest, Bucharest, 022328, Romania
-
Local Institution - 0074
Cluj-Napoca, 400015, Romania
-
Local Institution - 0075
Bucharest, 020335, Romania
-
Local Institution - 0076
Florești, Cluj, 407280, Romania
-
Local Institution - 0077
Craiova, Dolj, 200542, Romania
-
Local Institution - 0078
Iași, 700483, Romania
-
Local Institution - 0079
Lodz, Łódź Voivodeship, 93-338, Poland
-
Local Institution - 0080
Prabuty, Pomeranian Voivodeship, 82-550, Poland
-
Local Institution - 0081
Warsaw, Masovian Voivodeship, 03-411, Poland
-
Local Institution - 0084
Rondebosch, Western Cape, 7700, South Africa
Conditions
Explore the condition pages connected to this study.